Revvity, Inc. (RVTY)
As of Sep 20, 2026, Revvity, Inc. (RVTY) scores 6.0/10 on AlphaStocks' five-model composite, #52 of 168 Health Care stocks. At $143, RVTY trades 60% above its model fair value of $89.
Health Care / Health Care Equipment
S&P 500$143.40
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 5 of 5 models — high confidence
Data as of Sep 20, 2026
Is REVVITY, INC. a Good Investment in 2026?
REVVITY, INC. (RVTY) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates REVVITY, INC. as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.3% · ROC 26%. REVVITY, INC. currently trades 60% above its estimated fair value of $89. REVVITY, INC. ranks #52 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value. P/e of 69x implies high growth expectations. eps growth of -6% may not justify the premium.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Significantly above fair value
Lynch
Neutral
High PEG — growth premium · Stalwart
Greenblatt
Caution
Earnings yield 2.3% · ROC 26%
Frequently Asked Questions
Is REVVITY, INC. (RVTY) a good investment?
What is REVVITY, INC.'s Piotroski F-Score?
Is RVTY overvalued or undervalued?
How does RVTY compare to other Health Care stocks?
What do investment models say about RVTY?
Similar Stocks
Compare RVTY with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer